Golfo y O. Medio · Actualidad general · Gulf Daily News

Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trial

Publicado por Gulf Daily News · Baréin hace 18 h

Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumours to disappear or shrink in an early-stage ‌trial. J&J had gained access to…

Leer el artículo completo en Gulf Daily News Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.gdnonline.com)

Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trial

También te puede interesar

Vincent Kompany 'stable' in hospital after collapsing at Bayern Munich training

Ethiopian PM’s advisor: Tigrayan forces and others hinder stability

‘Da Hawaiian’ retains super heavyweight title at Power Slap 25 in Abu Dhabi

Saudi-led coalition says it destroyed Houthi ballistic missiles fired towards Yanbu and Taif

To bring down Netanyahu, Arab-Israeli parties ready for opposition alliance

France mobilizes 70,000 cops ahead of nationwide protests as Paris museums, businesses close for the day

Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trial

Compartir

También te puede interesar

Vincent Kompany 'stable' in hospital after collapsing at Bayern Munich training

Ethiopian PM’s advisor: Tigrayan forces and others hinder stability

‘Da Hawaiian’ retains super heavyweight title at Power Slap 25 in Abu Dhabi

Saudi-led coalition says it destroyed Houthi ballistic missiles fired towards Yanbu and Taif

To bring down Netanyahu, Arab-Israeli parties ready for opposition alliance

France mobilizes 70,000 cops ahead of nationwide protests as Paris museums, businesses close for the day